Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-003218-38Phase 2Terminated
Phase 2, randomised trial of bupivacaine in acute postoperative pain and bronchial carcinoma (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Time to first postoperative administration of PRN opioids. Started Jul 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-003218-38.